University of Kent biotechnology available for commercial use could cut costs of producing proteins for everything from diagnostics to cancer therapeutics. A recent collaboration between Kent scientists and the Science and Technology Facilities Council-supported Central Laser Facility (CLF), has affirmed the remarkable versatility of the technology in expanding the possibilities of protein production. The Vesicle Nucleating Peptide (VNp) technol…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.